Member Info for MAJOREM

After 10 years, I sold a decent chunk of my position realizing substantial losses. I'm actually encouraged by the stock's move today... down 10% isn't that bad. The fundamentals remain on trend, albeit a slower slope. Management was bordering on incompetent today with scant details. The market's size is huge and they are going to play a big role... I just now believe they will need to dilute again.

Another think that surprises me is the fact that this auditor's "warning" wasn't in every annual report since the company was founded!?

I believe the stock will regain the double-digits. I just can not bear the opportunity costs any longer. There are great investments in which to redeploy.

Live to fight another day. This hole is going to take a while to fill. But I'm holding about half my position to hopefully go on to recoup the entire loss. Just now will be nearly impossible to ever regain the opportunity costs of the time.

Sad but a bit of a relief.

Wow. What a great find. We're riding the right horse...

AIM down YTD

AIM underperforming Russell2000 YTD

Smarteye underperforming Seeing Machines YTD

Smarteye at 52-week low.

Small caps will have their day. Soon.

The reason SEYE can release names is likely because they are sacrificing price. Lower ASP = Less restrictive NDA. I am certainly biased, but the actual reviews of SEYE tech are not mine and are quite negative. My Mach-e DMS IS INCREDIBLE and helpful, and something that I will seek out in future cars...

Check out that Guardian backlog! WOW.

What is the difference between RNS and RNS Reach?

Regulatory News Services (RNS) | LSEG

Reach is an investor communication service aimed at assisting listed and unlisted companies to deliver non-regulatory news such as marketing messages, corporate and product information. It is based on the existing RNS UK-Regulatory service and has the same levels of efficiency, control and broad dissemination.

Seeing Machines and SmartEye remind me of a pair of companies/products here in the USA: Invisalign and SmileDirect Club. Invisalign's product is much more expensive, requires a professional to "install" but also reinvests in innovation and quality. Plus, Invisalign has a good relationship with its clients and learns from them. SmileDirect Club sells cheaper DIY kits and had countless lawsuits from its customers. Invisalign customers have straight teeth. SmileDirect customers have crooked teeth and often end up paying for additional orthodontic treatments to correct SmileDirect's complications.

After about a decade...

Invisalign is a growing, profitable multi billion dollar company. SmileDirect filed for bankruptcy.

Even cold fish know that Seeing Machines closely resembles Invisalign and SmartEye most resembles SmileDirect.

You forgot the obvious reason for any OEM to choose SEYE: price. They sell cheap, and try to make it up in volume. SEE priorities include integrity and profits.

For some reason I thought smarteye is in GM lately or at least sharing/splitting the current volumes?

I used Bloomberg to analyze the trading for SEE stock YTD 2024:

There have been 56 down days and 47 up days. There were 7 days that traded more than 10 million shares and 5 of them were "up" days, with 2 down days.

The sum of volume on up days was 267.2 million shares (£13.53M), where the sum of down volume was 249.1 million shares (£12.27M).

So even though the stock is down YTD and frustrating ALMOST everyone on this board, it is being accumulated and "bought" on a net basis.

These stats are just the facts.

But my highest conviction opinion is that it is absolutely insane that SmartEye has a market value of approximately $370M vs SEE's $252M. This will not persist.

I'm starting an index that will sum the 4 primary DMS companies' market values (Tobii, SmartEye, Cipia and Seeing Machines). Let me know quickly if there is a public company missing from this list that is pure-play DMS.

They won't know intra-quarter (like Fleet kms). KPIs stair-step... they don't trickle in, unfortunately.

They compete/win with price... selling for

For trimming at the bottom. It was like a viking sacrifice... to save the rest of the clan.

That chart should make it obvious to anyone with a brain that the AIM can misprice companies materially...

GLA. I'm back into hibernation as my spirits were much higher and calmer when not reading this board. Longs well be rewarded handsomely.

I sold a little... at a loss of course. Thank me later because my patience is historically a great guide as I often pick the bottom when I sell. My gut wanted me to buy more.

What I can say is that this board has devolved into a pit. I miss the knowledge.

I'll check back in a month.

In terms of Paul, he'll make a about a million bucks if the stock gets to 12p. I'd say that's an alignment of his interests with ours...

The only issue that matters: will the company need to issue more shares to get them to profitability.

I have as much optimism as ever on the future sales outlook for all the major DMS players. The question is, what number do I use to divide the pie? (How many shares outstanding)?

It's really important that they are creative and cut any fat until that point.

And head of PR Sophie doesn't even return messages... or if she does, it's after an incredibly long delay!

Sad, really.

Safestocks was the first resource to post (eventually time proved correct): Cadillac, Ford and BMW. A better prediction "record" than anyone else I know on SEE.

The AIM is just a black hole for almost any stock... surprisingly it's still a legal trading exchange!?

OPTHEA did it, GW Pharma did it, Avita did it, many others... Essentially you IPO on US exchange to effect the dual-listing... End result is company raises a little capital (and finds a real market price). Reverse split in conjunction. Do this if the company needs any money... NOT the buzz-saw capital raise that is otherwise known as the AIM exchange...

If they don't need amy capital, moot. If they did, they could absolutely hold their own over in USA and would be eligible for Russell2000 inclusion which would be a second boost!

I hear you. I know they've been consistent on the topic. I will be furious if they raise any more capital via a dilutive AIM offering rather than a IPO/relist on NASDAQ.

FWIW, The new companies being added to the Russell2000 this year have a market capitalization of around $150 million USD... SEE is plenty big enough.

The reason it's important to consider is that it needs to trade on a liquid exchange in order to get a fair value... prior to the inevitable takeover offer(s). Nobody will offer more than a 30%-100% premium to the "market price."

Whereas SEE could probably earn a price/sales ratio of around 6x-8x forward revenues in the US as soon as it becomes profitable. Then get a premium on THAT for the expected growth and IP and high margin...